British American Tobacco vs Legal & General: which has the better dividend forecast for 2024?

British American Tobacco and Legal & General shares both carry yields above 8% for next year. But which of their dividend forecasts looks more realistic?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investor demand for British American Tobacco (LSE:BATS) and Legal & General Group (LSE:LGEN) shares have leapt in recent days. This is thanks in part to the eye-grabbing dividend forecasts that both FTSE 100 stocks offer for 2024.

The blue-chip cigarette manufacturer carries a mighty 10.9% dividend yield for next year. Its fellow Footsie share meanwhile, yields a lower-but-still-impressive 8.7%.

Both readings beat the Footsie’s forward average of 3.9% by a huge margin. But which has the better dividend prospects for the new year? And which one (if any) should I buy for my UK shares portfolio?

Poor dividend coverage

Of course, dividends can never be guaranteed and unexpected trading problems can cause havoc for a company’s payout policy.

In the case of BAT shares, weak dividend cover suggests any unexpected profits trouble could throw predicted payouts off course. Forecasts of an increased full-year payout of 249.4p per share is covered just 1.5 times by anticipated earnings.

This is well below the widely regarded security benchmark of 2 times and above. And in this respect Legal & General fares even worse — an improved 21.36p per share dividend forecast is covered just 1.2 times.

Strong balance sheet

However, Legal & General’s strong balance sheet means it looks in a great position to meet next year’s forecast reward.

The insurer’s Solvency II capital ratio improved to an impressive 230% as of June. Capital generation came in at £5.9bn during the first half, a figure that comfortably exceeded dividends of £3.6bn.

Things can change, of course. But encouragingly, back in August, the company said its capital generation and dividend programme for 2019-2024 remains on track. These are set to range £8bn-£9bn and £5.6bn-£5.9bn respectively by next year.

Weak balance sheet

British American Tobacco’s large debts mean it doesn’t look anywhere near as financially robust. Net debt stood at a hulking $37.8bn as of June.

The company has also said it expects adjusted net debt to adjusted EBITDA to sit at 2.7 times at the end of 2023. This is towards the higher end of its target range of 2 to 3 times.

BATS’ decided to stop share buybacks earlier this year to get to grips with its large financial liabilities. And I fear this could eventually impact the firm’s dividends.

The verdict

My concerns have increased further following the firm’s disappointing trading update this month. As well as writing down the value of its US brands by $25bn, it said revenues growth for 2023 would come in at the lower end of its 3-5% target.

Soaring demand in its non-combustible products (like the glo tobacco-heated product) provides a chink of light for British American Tobacco. But the company could still struggle next year given the tough economic outlook and growing popularity of illegal vapes.

Life insurance businesses also faces difficulties in 2024 if the global economy splutters. Yet despite this, the strength of Legal & General’s balance sheet means it appears in great shape to pay the gigantic dividends analysts are expecting. It certainly looks stronger than BATS on this front.

I already own shares in the financial services giant and I’m looking to add more to my portfolio soon to boost my passive income.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Legal & General Group Plc. The Motley Fool UK has recommended British American Tobacco P.l.c. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s the best-performing FTSE 100 stock of the last 10 years

Private equity firm 3i has outperformed the rest of the FTSE 100 over the last 10 years. And its big…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

Here’s why Warren Buffett is selling shares (and why I’m not)

Warren Buffett cited tax considerations as his reason for selling shares in Apple. But this isn’t something most UK investors…

Read more »

Investing Articles

What on earth is going on with the AstraZeneca share price?

The AstraZeneca share price has fallen 30% from its peak in August. Dr James Fox explains what’s going on with…

Read more »

Investing Articles

2 high-yield FTSE 100 shares I’d consider buying for passive income…and one I’d avoid

Some FTSE 100 stocks have eye-popping dividend yields. But will the passive income actually be dished out? Paul Summers takes…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

These 2 former stock market darlings are trying my patience! Time to sell?

Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks.…

Read more »

Investing Articles

Here’s how I’d use £3,000 to target a second income that grows each year

Our writer explains the approach he'd take to trying to build a second income that gets bigger over time, by…

Read more »

Elevated view over city of London skyline
Investing Articles

Is it time to buy this incredible FTSE dividend share?

Christopher Ruane examines one FTSE 100 share with a phenomenal dividend history. Does a steep share price fall this year…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

This FTSE 100 share has just crashed another 20%. Its P/E is now just 9.9 so should I buy?

Harvey Jones was tempted to buy this FTSE 100 share after it crashed in October. Now it's crashed again, it…

Read more »